biotech peptides tirzepatide Premium Peptide | Dual Agonist The trillion-dollar peptide. Appearing on

D.et al (2006)

The FDA approved oral semaglutide (the Wegovy pill) for weight management in December 2025, giving patients a daily tablet option alongside the traditional once-weekly injection

The first hormone, GLP-1 , helps reduce appetite and slows stomach emptying

Its composition includes: Herbal Complex: A combination of natural extracts with a thermogenic effect

Collectively, we show that while GIPR agonism and antagonism have similar effects on body weight and food intake, they do so via different neuronal mechanisms, with GIPR antagonism, but not GIPR agonism, depending on GLP-1R signalling to affect energy metabolism